AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

Gastroenterology. 2020 Apr 10;S0016-5085(20)30482-0.doi: 10.1053/j.gastro.2020.04.012. Online ahead of print.

David T Rubin 1, Joseph D Feuerstein 2, Andrew Y Wang 3, Russell D Cohen 4


Author information

1University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL. Electronic address: drubin@uchicago.edu.

2Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, MA.

3Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA.

4University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL.


Description: The purpose of this AGA Institute Clinical Practice Update is to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic.

Methods: This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.